Biologics Quality Control Testing
Clinical
Diagnostic
Biologics Quality Control Testing
Clinical
Diagnostic
ABOUT US
The NGS-based technology the company developed is used for:
• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GLP level
• The diagnosis of infections (including sepsis) based on blood samples
PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.
LATEST NEWS
Viral Safety Expert, Audrey Brussel, joins PathoQuest
NewsPour la version en français de ce communiqué de presse : cliquez ici Audrey Brussel brings her industrial expertise to support the development of added-value services for the quality control of biologics PARIS, FRANCE – December 10, 2020 – PathoQuest, a leader in...
PathoQuest receives PM’up Relance Industrie Île-de-France grant to expand biologic testing capabilities at Paris site
Press ReleasePour la version en français de ce communiqué de presse : cliquez ici Company awarded €500,000 to support scale up and industrialization of its facilities dedicated to quality control testing for biologicsParis, France – November 26, 2020 – PathoQuest, a...
Charles River and PathoQuest Strengthen Strategic Partnership
Press ReleasePour la version en français de ce communiqué de presse : cliquez ici PathoQuest establishes U.S. subsidiary with state-of-the-art biologics genomic testing laboratory in Wayne, PA to expand its next-generation sequencing capabilities.WILMINGTON, MA and...
Let’s Start Something New
Welcome to PathoQuest!